The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): The phase II AVETUX-CRC trial (AIO KRK 0216).
 
Alexander Stein
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck KGaA; Roche
Speakers' Bureau - Amgen; Bayer; Celgene; Lilly; Merck KGaA; Roche; Sanofi; Servier
Research Funding - Merck KGaA (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Roche
 
Mascha Binder
Honoraria - Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Chugai Pharma; Hexal
 
Carsten Bokemeyer
Honoraria - Bayer; Bristol-Myers Squibb; Merck KGaA; Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Hexal; Lilly/ImClone; Merck Serono; Mundipharma; Sanofi
Travel, Accommodations, Expenses - Merck Serono; Sanofi
 
Salah Eddin Al Batran
No Relationships to Disclose
 
Axel Hinke
Honoraria - Roche
 
Susanna Hegewisch-Becker
Consulting or Advisory Role - Lilly; Merck KGaA
Research Funding - Lilly; MOLOGEN; Roche
Travel, Accommodations, Expenses - Merck KGaA